313 related articles for article (PubMed ID: 11358903)
21. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
[TBL] [Abstract][Full Text] [Related]
22. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
[TBL] [Abstract][Full Text] [Related]
23. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
24. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population.
Deschoolmeester V; Van Damme N; Baay M; Claes K; Van Marck E; Baert FJ; Wuyts W; Cabooter M; Weyler J; Vermeulen P; Lardon F; Vermorken JB; Peeters M
Eur J Cancer; 2008 Oct; 44(15):2288-95. PubMed ID: 18707864
[TBL] [Abstract][Full Text] [Related]
26. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma.
Caduff RF; Johnston CM; Svoboda-Newman SM; Poy EL; Merajver SD; Frank TS
Am J Pathol; 1996 May; 148(5):1671-8. PubMed ID: 8623934
[TBL] [Abstract][Full Text] [Related]
27. Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer.
Zhang B; Yao K; Zhou E; Zhang L; Cheng C
Cancer Res; 2021 Apr; 81(8):1977-1987. PubMed ID: 33619118
[TBL] [Abstract][Full Text] [Related]
28. Microsatellite instability in sporadic-colon-cancer patients with and without liver metastases.
Chen WS; Chen JY; Liu JM; Lin WC; King KL; Whang-Peng J; Yang WK
Int J Cancer; 1997 Aug; 74(4):470-4. PubMed ID: 9291442
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability in gastrointestinal tract tumours.
Philp AJ; Phillips WA; Rockman SP; Vincan E; Baindur-Hudson S; Burns W; Valentine R; Thomas RJ
Int J Surg Investig; 2000; 2(4):267-74. PubMed ID: 12678528
[TBL] [Abstract][Full Text] [Related]
30. The clinical features of rectal cancers with high-frequency microsatellite instability (MSI-H) in Japanese males.
Ishikubo T; Nishimura Y; Yamaguchi K; Khansuwan U; Arai Y; Kobayashi T; Ohkura Y; Hashiguchi Y; Tanaka Y; Akagi K
Cancer Lett; 2004 Dec; 216(1):55-62. PubMed ID: 15500949
[TBL] [Abstract][Full Text] [Related]
31. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified.
Ward RL; Turner J; Williams R; Pekarsky B; Packham D; Velickovic M; Meagher A; O'Connor T; Hawkins NJ
J Pathol; 2005 Dec; 207(4):377-84. PubMed ID: 16175654
[TBL] [Abstract][Full Text] [Related]
32. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
33. Microsatellite instability in sporadic and inherited colon adenocarcinomas from Greek patients: correlation with several clinicopathological characteristics.
Michalopoulos NV; Saetta AA; Lazaris AC; Gigelou F; Koilakou S; Patsouris E
Acta Gastroenterol Belg; 2005; 68(3):294-301. PubMed ID: 16268414
[TBL] [Abstract][Full Text] [Related]
34. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma.
Modica I; Soslow RA; Black D; Tornos C; Kauff N; Shia J
Am J Surg Pathol; 2007 May; 31(5):744-51. PubMed ID: 17460459
[TBL] [Abstract][Full Text] [Related]
35. Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma.
Wright CM; Dent OF; Newland RC; Barker M; Chapuis PH; Bokey EL; Young JP; Leggett BA; Jass JR; Macdonald GA
Gut; 2005 Jan; 54(1):103-8. PubMed ID: 15591513
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age.
Liang JT; Huang KC; Cheng AL; Jeng YM; Wu MS; Wang SM
Br J Surg; 2003 Feb; 90(2):205-14. PubMed ID: 12555297
[TBL] [Abstract][Full Text] [Related]
37. A comparison of colon and rectal somatic DNA alterations.
Slattery ML; Curtin K; Wolff RK; Boucher KM; Sweeney C; Edwards S; Caan BJ; Samowitz W
Dis Colon Rectum; 2009 Jul; 52(7):1304-11. PubMed ID: 19571709
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype.
Chaves P; Cruz C; Lage P; Claro I; Cravo M; Leitão CN; Soares J
J Pathol; 2000 Aug; 191(4):355-60. PubMed ID: 10918209
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.
Colombino M; Cossu A; Manca A; Dedola MF; Giordano M; Scintu F; Curci A; Avallone A; Comella G; Amoruso M; Margari A; Bonomo GM; Castriota M; Tanda F; Palmieri G
Ann Oncol; 2002 Sep; 13(9):1447-53. PubMed ID: 12196371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
